The in-silico studies offer valuable insights into discovering selective COX-2 inhibitors for potential therapeutic and pharmacological applications. The findings provide a strong foundation for future experimental validation and the development of anti-inflammatory medicine.
Xavier et al. (Thu,) studied this question.